Reckitt Benckiser Group (LON:RKT) Earns Hold Rating from HSBC

HSBC reissued their hold rating on shares of Reckitt Benckiser Group (LON:RKT) in a research note published on Thursday morning, MarketBeat.com reports.

Reckitt Benckiser Group Stock Performance

LON RKT opened at GBX 4,167 ($51.87) on Thursday. The company has a quick ratio of 0.46, a current ratio of 0.64 and a debt-to-equity ratio of 100.80. The company has a market capitalization of £29.52 billion, a P/E ratio of 1,835.68, a P/E/G ratio of 3.76 and a beta of 0.07. Reckitt Benckiser Group has a 12-month low of GBX 4,102.64 ($51.07) and a 12-month high of GBX 6,570 ($81.79). The firm has a 50-day moving average price of GBX 4,863.91 and a two-hundred day moving average price of GBX 5,322.53.

Reckitt Benckiser Group Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, May 24th. Shareholders of record on Thursday, April 11th will be issued a GBX 115.90 ($1.44) dividend. The ex-dividend date of this dividend is Thursday, April 11th. This represents a yield of 1.99%. This is an increase from Reckitt Benckiser Group’s previous dividend of $76.60. Reckitt Benckiser Group’s payout ratio is currently 8,502.20%.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.